Skip to main content
Isaac Francis Photo
Isaac Francis

Isaac Francis

GrafaFinance Journalist

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.

Articles by Isaac Francis

Grafa
Health

Pharming reports positive Phase II results for leniolisib in rare immune disorders

Pharming Group (NASDAQ:PHAR) announced positive topline results from a Phase II study evaluating leniolisib in patients with genetically identifiable primary immunodeficiencies (PIDs) associated with immune dysregulation caused by PI3Kδ signaling abnormalities.

Read more: Pharming reports positive Phase II results for leniolisib in rare immune disorders
Grafa
Health

Tiziana Life Sciences completes Phase 2a intranasal foralumab MS trial enrollment

Tiziana Life Sciences (NASDAQ:TLSA) announced that the final patient has completed the final visit in its Phase 2a INFORM-MS clinical trial evaluating intranasal foralumab in patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS).

Read more: Tiziana Life Sciences completes Phase 2a intranasal foralumab MS trial enrollment